Camber Capital Management LP - Significant Ownership

Signature - Title
/s/ Sean George - Chief Financial Officer
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Camber Capital Management LP.

Significant Ownership of Camber Capital Management LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PTCT PTC THERAPEUTICS, INC. Common Stock $0.001 par value per share 4.15% $137M 3.2M Camber Capital Management LP Dec 31, 2024
INGN Inogen Inc Common Stock, $0.001 par value 3.7% $6.91M 975K Camber Capital Management LP Mar 31, 2025
MYGN MYRIAD GENETICS INC Common Stock, par value $0.01 per share 3.41% $26.2M 3.1M Camber Capital Management LP Dec 31, 2024
BKD Brookdale Senior Living Inc. Common Stock, $0.01 par value 2.7% $39.4M -$68.8M 6.25M -63.6% Camber Capital Management LP Mar 31, 2025
OSUR ORASURE TECHNOLOGIES INC Common Stock, $0.000001 par value 1.2% $3.03M 900K Camber Capital Management LP Mar 31, 2025
SLDB Solid Biosciences Inc. Common Stock,$0.001 par value per share 0% $0 0 Camber Capital Management LP Dec 31, 2024
ZIMV ZimVie Inc. Common Stock, par value $0.01 per share 0% $0 -$30.2M 0 -100% Camber Capital Management LP Jul 21, 2025
PBYI PUMA BIOTECHNOLOGY, INC. Common Stock, par value $0.0001 per share 0% $0 0 Camber Capital Management LP Dec 31, 2024

Schedules 13D/G Reported by Camber Capital Management LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.